Biomerica Inc. (BMRA) stock prices were up by 2.53% as of the market closing on October 18th, 2021. This brought the price per share up to USD$5.68. Subsequent premarket fluctuations saw the stock rise by 7.39%, bringing it up to USD$6.10.
Proliferation of EZ Detect
October 19th 2021 saw BMRA stock announced that Walmart had commenced in store sales and rollout of its EZ Detect colorectal disease screening test within Walmart retail system across the nation. The EZ Detect product has been shipped by Biomerica to Walmart distribution centers in the US, with the product is projected to be on the shelf in over 4,600 Walmart Stores nationwide over the next two weeks. The in-store retail placement follows Biomerica’s previous announcement in early October, wherein the company began sales of EZ Detect product for online purchase through Walmart.com.
BMRA Stock Builds on Success
The company has hired an internal digital and social media team as a part of its ongoing sales strategy. This serves to increase the company’s presence on all major social communication platforms, thereby raising awareness for its at home testing products. Furthermore, Biomerica is in negotiations with several large partners for the distribution of the EZ Detect product in Asia, Europe, and the Middle East.
About EZ Detect
The EZ Detect colon disease screening test is the simplest at-home test to detect occult blood in a person’s stool. This can be indicative of early warning sign of colorectal diseases, including colon and rectal cancers. The test does not require the handling of stool or dietary restrictions, with the test pad being placed into the toilet after a bowel movement. A change in the pad’s color to blue/green within two minutes would indicate the presence of blood in the stool. The pad is then simply flushed down the toilet. The company is excited to broaden its relationship with Walmart to facilitate the proliferation of EZ Detect in stores at retail locations across the country. Furthermore, the company is facilitating their online sales channel.
Future Outlook for BMRA Stock
BMRA stock is keen to facilitate the expansive proliferation of the EZ Detect treatment across Walmart locations across the world. The company is poised to capitalize on the expanded scope of opportunities presented to it as a result of these developments. Current and potential investors are hopeful that management will be able to leverage the resources at its disposal effectively. This is hoped to facilitate significant and sustained increases in shareholder value over the long term.